Publikationen, an denen er mitarbeitet José Álvarez Sabin (64)

2023

  1. Intensive 90-day textile wearable Holter monitoring: an alternative to detect paroxysmal atrial fibrillation in selected patients with cryptogenic stroke

    Heart and Vessels, Vol. 38, Núm. 1, pp. 114-121

2022

  1. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  3. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  2. Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma

    Brain, Vol. 144, Núm. 8, pp. 2416-2426

2014

  1. Guía para el tratamiento del infarto cerebral agudo

    Neurologia

  2. Guía para el tratamiento preventivo del ictus isquémico y AIT (II). Recomendaciones según subtipo etiológico

    Neurologia

  3. How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up

    Journal of Neurology, Vol. 261, Núm. 8, pp. 1614-1621

  4. Predictive value of ankle-brachial index and PAI-1 in symptomatic intracranial atherosclerotic disease recurrence

    Atherosclerosis, Vol. 233, Núm. 1, pp. 186-189

2013

  1. Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts

    Cerebrovascular Diseases, Vol. 35, Núm. 1, pp. 81-88

  2. Guías de actuación clínica en la hemorragia intracerebral

    Neurologia

  3. Los costes del ictus en España según su etiología. El protocolo del estudio CONOCES

    Neurologia, Vol. 28, Núm. 6, pp. 332-339

  4. Predictive value of brain and vascular imaging including intracranial vessels in transient ischaemic attack patients: External validation of the ABCD3-I score

    European Journal of Neurology, Vol. 20, Núm. 7, pp. 1088-1093

  5. Recurrent transient ischaemic attack and early risk of stroke: Data from the PROMAPA study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 84, Núm. 6, pp. 596-603

2012

  1. Guía para el tratamiento preventivo del ictus isquémico y AIT (I). Actuación sobre los factores de riesgo y estilo de vida

    Neurologia

  2. Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: A comparison of prognostic risk scores

    Cerebrovascular Diseases, Vol. 33, Núm. 2, pp. 182-189

2011

  1. Lipoprotein-associated phospholipase A 2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease

    Atherosclerosis, Vol. 218, Núm. 1, pp. 181-187

  2. Plan de asistencia sanitaria al ICTUS II. 2010

    Neurologia, Vol. 26, Núm. 7, pp. 383-396

2009

  1. C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses

    Cerebrovascular Diseases, Vol. 28, Núm. 1, pp. 95-102